Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Safety of Ultrasound-Guided Fine Needle Aspiration Biopsy of Neck Lesions in Patients Taking Antithrombotic/Anticoagulant Medications

Safety of Ultrasound-Guided Fine Needle Aspiration Biopsy of Neck Lesions in Patients Taking... Downloaded from http://journals.lww.com/ultrasound-quarterly by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/10/2020 ORIGINAL RESEARCH Safety of Ultrasound-Guided Fine Needle Aspiration Biopsy of Neck Lesions in Patients Taking Antithrombotic/Anticoagulant Medications Monzer M. Abu-Yousef, MD, Joshua H. Larson, MD, PhD, David M. Kuehn, MD, Andrew S. Wu, MD, and Archana T. Laroia, MD 3,4 suspected metastases. During preprocedural review of pa- Abstract: We examined records of patients who underwent ultrasound- tients’ medical records, a sizeable subset of patients referred guided fine needle aspiration biopsy (USGFNAB) of neck lesions for USGFNAB are found to be taking antithrombotic and/or to determine whether there was a significantly increased incidence anticoagulant (AT/AC) medications. This creates a dilemma of bleeding complications in patients on antithrombotic and/or anti- for the radiologist and the referring physician, who must weigh coagulant (AT/AC) medications compared to patients not receiving the risk of withholding these medications (and the associated AT/AC therapy. Our institutional review board approved this Health potential benefit of diagnosis) against the perceived increased Insurance Portability and Accountability Act-compliant retrospective risk of iatrogenic bleeding. There are published studies des- examination of patients’ medical data without requiring informed cribing the safety of core needle biopsies of the breast, ab- consent. The records of 593 patients http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Ultrasound quarterly Wolters Kluwer Health

Safety of Ultrasound-Guided Fine Needle Aspiration Biopsy of Neck Lesions in Patients Taking Antithrombotic/Anticoagulant Medications

Loading next page...
 
/lp/wolters-kluwer-health/safety-of-ultrasound-guided-fine-needle-aspiration-biopsy-of-neck-LBcMLRpRvU

References (16)

Publisher
Wolters Kluwer Health
ISSN
0894-8771
eISSN
1536-0253
DOI
10.1097/RUQ.0b013e31822b5681
Publisher site
See Article on Publisher Site

Abstract

Downloaded from http://journals.lww.com/ultrasound-quarterly by BhDMf5ePHKbH4TTImqenVA5KvPVPZ0P5BEgU+IUTEfzO/GUWifn2IfwcEVVH9SSn on 06/10/2020 ORIGINAL RESEARCH Safety of Ultrasound-Guided Fine Needle Aspiration Biopsy of Neck Lesions in Patients Taking Antithrombotic/Anticoagulant Medications Monzer M. Abu-Yousef, MD, Joshua H. Larson, MD, PhD, David M. Kuehn, MD, Andrew S. Wu, MD, and Archana T. Laroia, MD 3,4 suspected metastases. During preprocedural review of pa- Abstract: We examined records of patients who underwent ultrasound- tients’ medical records, a sizeable subset of patients referred guided fine needle aspiration biopsy (USGFNAB) of neck lesions for USGFNAB are found to be taking antithrombotic and/or to determine whether there was a significantly increased incidence anticoagulant (AT/AC) medications. This creates a dilemma of bleeding complications in patients on antithrombotic and/or anti- for the radiologist and the referring physician, who must weigh coagulant (AT/AC) medications compared to patients not receiving the risk of withholding these medications (and the associated AT/AC therapy. Our institutional review board approved this Health potential benefit of diagnosis) against the perceived increased Insurance Portability and Accountability Act-compliant retrospective risk of iatrogenic bleeding. There are published studies des- examination of patients’ medical data without requiring informed cribing the safety of core needle biopsies of the breast, ab- consent. The records of 593 patients

Journal

Ultrasound quarterlyWolters Kluwer Health

Published: Sep 1, 2011

There are no references for this article.